Page 1 | Search Results | Blood Advances | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa

Nmazuo W. Ozuah, Joseph Lubega, Carl E. Allen, Nader Kim El-Mallawany

Blood Adv (2020) 4 (16): 4007–4019.

https://doi.org/10.1182/bloodadvances.2020002178

Published: 2020

Journal Articles

Cranberry A-type proanthocyanidins selectively target acute myeloid leukemia cells

Laura M. Bystrom, Daniel P. Bezerra, Hsiao-Ting Hsu, Hongliang Zong, Luis A. Lara-Martínez, Jeanne P. De Leon, Megan Emmanuel, David Méry, Sara Gardenghi, Duane Hassane, Catherine C. Neto, Susanna Cunningham-Rundles, Michael W. Becker, Stefano Rivella, Monica L. Guzman

Blood Adv (2019) 3 (21): 3261–3265.

https://doi.org/10.1182/bloodadvances.2018026633

Published: 2019

Includes: Supplemental data

Journal Articles

Disparities in place of death for patients with hematological malignancies, 1999 to 2015

Fumiko Chino, Arif H. Kamal, Junzo Chino, Thomas W. LeBlanc

Blood Adv (2019) 3 (3): 333–338.

https://doi.org/10.1182/bloodadvances.2018023051

Published: 2019

Journal Articles

Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study

Marius Flasinski, Kira Scheibke, Martin Zimmermann, Ursula Creutzig, Katarina Reinhardt, Femke Verwer, Valerie de Haas, Vincent H. J. van der Velden, Christine von Neuhoff, C. Michel Zwaan, Dirk Reinhardt, Jan-Henning Klusmann

Blood Adv (2018) 2 (13): 1532–1540.

https://doi.org/10.1182/bloodadvances.2018018945

Published: 2018

Includes: Supplemental data

Journal Articles

The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective

James N. George

Blood Adv (2018) 2 (12): 1510–1516.

https://doi.org/10.1182/bloodadvances.2018018432

Published: 2018

Journal Articles

Risk and timing of cardiovascular death among patients with myelodysplastic syndromes

Andrew M. Brunner, Traci M. Blonquist, Gabriela S. Hobbs, Philip C. Amrein, Donna S. Neuberg, David P. Steensma, Gregory A. Abel, Amir T. Fathi

Blood Adv (2017) 1 (23): 2032–2040.

https://doi.org/10.1182/bloodadvances.2017010165

Published: 2017

Includes: Supplemental data

NARROW

Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa

Cranberry A-type proanthocyanidins selectively target acute myeloid leukemia cells

Disparities in place of death for patients with hematological malignancies, 1999 to 2015

Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study

The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective

Risk and timing of cardiovascular death among patients with myelodysplastic syndromes

Email alerts

ASH Publications

American Society of Hematology

Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa

Cranberry A-type proanthocyanidins selectively target acute myeloid leukemia cells

Disparities in place of death for patients with hematological malignancies, 1999 to 2015

Low-dose cytarabine to prevent myeloid leukemia in children with Down syndrome: TMD Prevention 2007 study

The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective

Risk and timing of cardiovascular death among patients with myelodysplastic syndromes

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only